MARKET

DBVT

DBVT

Dbv Technologies S A
NASDAQ
20.00
-0.21
-1.04%
After Hours: 20.00 0 0.00% 16:04 03/27 EDT
OPEN
20.77
PREV CLOSE
20.21
HIGH
21.59
LOW
19.70
VOLUME
275.60K
TURNOVER
--
52 WEEK HIGH
26.19
52 WEEK LOW
3.910
MARKET CAP
5.92B
P/E (TTM)
-3.8125
1D
5D
1M
3M
1Y
5Y
1D
DBV Technologies Sets Stage For 'Swift' Success As Breakthrough Peanut Patch Nears FDA Submission
Benzinga · 22h ago
Alphabet To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday
Benzinga · 1d ago
DBV Technologies Is Maintained at Market Outperform by Citizens
Dow Jones · 1d ago
Citizens Maintains Market Outperform on DBV Technologies, Raises Price Target to $47
Benzinga · 1d ago
DBV Technologies SA – American (DBVT) Gets a Buy from Cantor Fitzgerald
TipRanks · 1d ago
DBV Technologies Price Target Maintained With a $51.00/Share by Guggenheim
Dow Jones · 1d ago
Guggenheim Reiterates Buy on DBV Technologies, Maintains $51 Price Target
Benzinga · 1d ago
Analysts Offer Insights on Healthcare Companies: DBV Technologies SA – American (DBVT) and Meiragtx Holdings (MGTX)
TipRanks · 1d ago
More
About DBVT
DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The Company's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The Company operates one subsidiary DBV Technologies Inc. in the United States.

Webull offers DBV Technologies SA - ADR stock information, including NASDAQ: DBVT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DBVT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DBVT stock methods without spending real money on the virtual paper trading platform.